The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment.
about
Prevention of Hepatocellular CarcinomaHepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012.A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.Diagnosis of non-alcoholic fatty liver disease (NAFLD).Peretinoin as an adjuvant therapy for hepatocellular carcinoma.Downregulated long non-coding RNA DREH promotes cell proliferation in hepatitis B virus-associated hepatocellular carcinoma.Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy.The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort.Gastrointestinal Complications of Obesity.Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.Is nonalcoholic fatty liver disease driving the increased incidence of liver cancer?Long non-coding RNA Myd88 promotes growth and metastasis in hepatocellular carcinoma via regulating Myd88 expression through H3K27 modification.A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss.Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma.Collagen I promotes hepatocellular carcinoma cell proliferation by regulating integrin β1/FAK signaling pathway in nonalcoholic fatty liver.More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD.A case of ruptured hepatocellular carcinoma (HCC) in resolving non-alcoholic steatohepatitis associated with type 2 diabetes: Is early detection of diabetes-related HCC feasible?Eicosapentaenoic acid attenuates obesity-related hepatocellular carcinogenesis.Carrot juice ingestion attenuates high fructose-induced circulatory pro-inflammatory mediators in weanling Wistar rats.The contrasting roles of inflammasomes in cancer.Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment.Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinomaMolecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular CarcinomaNatural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
P2860
Q28079576-3E9B83D9-7EBA-4E83-9990-310EC35C3943Q30234574-E6E4CBE6-4687-40F2-BEC1-FB6FEA0E61B7Q37301595-DF369F64-4130-4D86-9AC3-53CAF175D4A1Q37644945-5E51BA17-8DCE-4BBC-AD2D-D2A0A000314BQ38430715-C6BE1745-089F-4DF5-8D60-F8E68CD736B4Q38752448-BD7525C8-C6C7-44A8-A35B-504016FEE84FQ38811383-78189BEE-D9CB-40F4-8CBF-56E8EB989650Q38959682-800D7A13-765A-428A-AAA0-9BEC671A7CC1Q40090479-B5CC6E68-B5C1-43ED-ABA4-8ACA99018B5FQ40149527-8AFCF031-078E-4955-9A2D-AF20BB0C6BE8Q40174512-E4B5B291-3570-4596-960F-F0C841C0D094Q40338492-AD1C41CA-83A2-4E10-A91A-4818B7628696Q41050215-D9840452-51E9-4741-B124-4B4FF9DA7510Q44232870-DFBCF30A-647C-48B9-A0D9-42561886BAA9Q44910961-C935A7CF-B296-4101-880B-2D75755D6AC9Q45399660-28CAF0AC-4EA8-4034-940D-0964B34F964CQ47103200-3D938623-7D0A-4BF7-AC92-CD94AE651B04Q47113983-2FE96A1E-B65A-49A2-8D04-BDB74C91C460Q47608704-B0732173-347C-41E3-9D98-B1AA353E1529Q47966842-F3E9AA48-C8B8-4EC4-9D96-9DC18BEA76DBQ48295173-876B16AD-7D18-41FE-B147-716B8E509128Q50080490-5289DBEE-D57D-4A50-AE61-253FBE5A0B50Q51640987-17E0DEF1-B54D-4F0B-9B9B-86EF76D164C4Q54486845-A447A1A7-323F-4D69-8789-D5BBFD2D611DQ55323878-1268851E-890A-4E9E-852E-988ABD7DE6D8Q57810975-1E387B3D-EBFD-44AE-A195-7A0CC7A66C7EQ58693431-E489BB37-80EC-40F1-B473-1EDE9517826FQ58764532-1E25593B-8437-4FAF-BAC2-2A6502161E62
P2860
The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The story of HCC in NAFLD: fro ...... , to prevention and treatment.
@en
type
label
The story of HCC in NAFLD: fro ...... , to prevention and treatment.
@en
prefLabel
The story of HCC in NAFLD: fro ...... , to prevention and treatment.
@en
P2860
P356
P1433
P1476
The story of HCC in NAFLD: fro ...... , to prevention and treatment.
@en
P2093
Cristina Margini
Jean F Dufour
P2860
P304
P356
10.1111/LIV.13031
P577
2015-11-25T00:00:00Z